BRIEF published on 08/10/2026 at 22:10, 1 month 12 days ago Elena Ridloff Joins Immunic's Board as Strategic Director Vidofludimus Calcium Immunic Board Elena Ridloff Biotechnology Leadership Phase 3 ENSURE
PRESS RELEASE published on 08/10/2026 at 22:05, 1 month 12 days ago Immunic Appoints Elena Ridloff to Board of Directors Immunic appoints Elena Ridloff, a financial and capital markets expert, to its Board of Directors, enhancing leadership as the company approaches pivotal phase 3 ENSURE Readout for Multiple Sclerosis treatments Board Of Directors Immunic Elena Ridloff MS Treatments ENSURE Readout
BRIEF published on 07/09/2026 at 12:35, 2 months 13 days ago Immunic annonce sa participation aux conférences investisseurs de juillet Biotechnologie Immunic Inc. Thérapies Orales Conférences D'investisseurs Maladies Neurologiques
BRIEF published on 07/09/2026 at 12:35, 2 months 13 days ago Immunic Announces Participation in July Investor Conferences Biotechnology Investor Conferences Immunic Inc. Oral Therapies Neurologic Diseases
PRESS RELEASE published on 07/09/2026 at 12:30, 2 months 14 days ago Immunic to Participate in Investor Conferences in July Immunic, Inc. (Nasdaq: IMUX) to participate in investor conferences in July, presenting at Leerink Partners Therapeutics Forum and B. Riley Securities Mind, Muscle & Vision Summit in Boston Investor Conferences Immunic Inc B. Riley Securities Neurologic Diseases Leerink Partners
BRIEF published on 06/10/2026 at 12:35, 3 months 12 days ago Immunic participe à des conférences clés en juin. Thérapies Orales Maladies Neurologiques Participation Immunitaire Conférences Sur La Biotechnologie Présentation De L'IMU-856
BRIEF published on 06/10/2026 at 12:35, 3 months 12 days ago Immunic Engages in Key Conferences this June Oral Therapies Neurologic Diseases Immunic Participation Biotechnology Conferences IMU-856 Presentation
PRESS RELEASE published on 06/10/2026 at 12:30, 3 months 13 days ago Immunic to Participate in Investor, Industry and Scientific Conferences in June Immunic, Inc. to participate in investor, industry, and scientific conferences in June. Presentation on IMU-856 at EFMC-ACSMEDI Symposium Conférences Investor Immunic Inc. Symposium IMU-856
BRIEF published on 05/28/2026 at 12:35, 3 months 25 days ago Immunic présente les résultats de l'essai CALLIPER de phase 2 lors du congrès CMSC 2026 Vidofludimus Calcium Immunitaire Données Cliniques Essai CALLIPER De Phase 2 Sclérose En Plaques Progressive
BRIEF published on 05/28/2026 at 12:35, 3 months 25 days ago Immunic Shares Phase 2 CALLIPER Trial Findings at CMSC Meeting 2026 Clinical Data Immunic Vidofludimus Calcium Progressive Multiple Sclerosis Phase 2 CALLIPER Trial
Published on 09/23/2026 at 09:05, 3 hours 27 minutes ago Algo Grande Copper Confirms 68.43 Metres of Copper-Silver-Gold Mineralization Across Two Zones in Hole AG-CG-PH2-002, Including a New Zone of 38.20 Metres at 1.0% CuEq
Published on 09/23/2026 at 08:00, 4 hours 32 minutes ago Caledonia Mining Corporation Plc: Notification of Relevant Change to Significant Shareholder
Published on 09/23/2026 at 07:30, 5 hours 2 minutes ago Tocvan Expands El Mezquite; Drilling Returns 106.8 m of 0.5 g/t Au
Published on 09/23/2026 at 04:45, 7 hours 47 minutes ago SAINT BELLA Marks First Anniversary at Waldorf Astoria Monarch Beach
Published on 09/23/2026 at 02:45, 9 hours 47 minutes ago Presentation to Beaver Creek Precious Metals Summit
Published on 09/23/2026 at 12:25, 7 minutes ago SANY Renewable Energy Reports Over 300% Overseas Revenue Growth at WindEnergy Hamburg 2026
Published on 09/23/2026 at 12:05, 27 minutes ago Constellation Cold Logistics ("Constellation") announced today the appointment of Abhy Maharaj as Chief Executive Officer
Published on 09/23/2026 at 12:00, 32 minutes ago Shanghai Electric Presents Three Energy Transition Solutions at Enlit Asia 2026
Published on 09/23/2026 at 11:46, 46 minutes ago Turkiye Garanti Bankasi A.S.: Intermediary Institution Warrants Issuance Application
Published on 09/23/2026 at 11:44, 48 minutes ago Seahawk Investments Expands Alternative Investment Platform with Launch of Maritime Private Credit Fund
Published on 09/23/2026 at 08:00, 4 hours 32 minutes ago Résultats semestriels 2026 - ANR par action : 101,90 €, en progression de 8,18 % - Capitaux propres consolidés : 774,5 M€
Published on 09/22/2026 at 18:00, 18 hours 32 minutes ago Consolidated results for the first half of 2026 EBITDA : 60,5 M€
Published on 09/22/2026 at 18:00, 18 hours 32 minutes ago Résultats consolidés du premier semestre 2026 EBITDA : 60,5 M€
Published on 09/22/2026 at 17:45, 18 hours 47 minutes ago Imerys-09-2026-information-share-capital-and-voting-rights-as-of-31-August-2026
